Royalty Pharma plc (RPRX)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:206
% of all portfolios:0.095%
Hold Price * :$28.29
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
Viking Global Investors Add 1.04% 123,963 0.01
Torray Funds Add 23.70% 164,361 0.65
Samantha McLemore - Patient Capital Management Add 43.30% 616,805 0.86
Q2  2024
Samantha McLemore - Patient Capital Management Add 0.32% 4,572 0.01
Viking Global Investors Add 4.22% 484,511 0.05
Torray Funds Add 3.51% 23,498 0.09
Q1  2024
Viking Global Investors Add 13.86% 1,398,130 0.16
Samantha McLemore - Patient Capital Management Add 13.15% 165,038 0.24
Torray Funds Add 32.49% 164,320 0.75
Q4  2023
Viking Global Investors Add 6.58% 623,216 0.06
Torray Funds Add 22.56% 93,107 0.42
Samantha McLemore - Patient Capital Management Buy 1,254,780 1.87
Q2  2023
Torray Funds Add 201.68% 276,643 1.47
Q1  2023
Viking Global Investors Add 11.95% 1,195,738 0.20
Q3  2022
Torray Funds Add 0.01% 12 0.00
Q2  2022
Torray Funds Add 5.26% 6,942 0.06
Viking Global Investors Add 14.92% 1,606,222 0.31
Q1  2022
Viking Global Investors Add 4.35% 449,094 0.07
Q4  2021
Viking Global Investors Add 149.13% 6,174,870 0.71
Torray Funds Buy 137,941 0.81
Q3  2021
Viking Global Investors Add 27.85% 901,854 0.09
Warren Buffett - Berkshire Hathaway Buy 13,145,902 0.16
Q2  2021
Viking Global Investors Add 57.08% 1,176,901 0.15
Q1  2021
Lee Ainslie - Maverick Capital Buy 7,342 0.00
Q4  2020
Viking Global Investors Add 17.40% 338,936 0.05
Q2  2020
Viking Global Investors Buy 2,514,985 0.53

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.